Mahallawi, W. Novel Bivalent Mucosal Antigen Formulation Targeting SARS-CoV-2 and Influenza: Immunogenicity Assessment Using Zan in Vitro Human Nasal-Associated Lymphoid Tissue Model. pjvs 2026, 29, 281–289.